Intuitive Surgical Surpasses Analysts’ 12-Month Target Price
In recent trading, shares of Intuitive Surgical Inc (Symbol: ISRG) have crossed above the average analyst 12-month target price of $510.43, trading at $521.15/share. When a stock hits its target price, analysts typically face two choices: downgrade due to valuation concerns or raise their target to a higher level. The decision often hinges on significant business developments that may be driving the stock price upwards. If the outlook for the company appears promising, raising the target may be warranted.
Understanding Analyst Targets and Performance
There are 23 different analyst targets within the Zacks coverage universe that contribute to the average for Intuitive Surgical Inc. However, an average is just a numerical representation; it does not capture the full range of opinions. For instance, one analyst has set a price target as low as $415.00, while another has projected a high of $586.00. The standard deviation among these targets stands at $49.492.
A Collective Perspective on ISRG’s Future
The reason for examining the average ISRG price target lies in leveraging the “wisdom of crowds” approach. This method combines insights from multiple experts, rather than relying solely on one opinion. With ISRG now trading above the average target price of $510.43/share, investors are encouraged to evaluate the company’s potential. They must consider whether this price point is a stepping stone toward even higher targets or if the valuation has become too stretched, prompting a reevaluation of their investment strategy.
| Recent ISRG Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong buy ratings: | 15 | 15 | 15 | 14 |
| Buy ratings: | 2 | 2 | 2 | 2 |
| Hold ratings: | 8 | 8 | 8 | 8 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.72 | 1.72 | 1.72 | 1.75 |
The average rating shown is based on a scale from 1 to 5, where 1 is Strong Buy and 5 is Strong Sell. This analysis utilized data from Zacks Investment Research, provided via Quandl.com. Please refer to the latest Zacks research report on ISRG — available for free.
The Top 25 Broker Analyst Picks of the S&P 500 »
Additional Resources:
• High Beta Stocks
• Institutional Holders of GXC
• Funds Holding ELF
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
